Authorization.eutics Receives Orphan Drug Designation for Ophthalmic Drug To Viral Eye Infection – Sirion Therapeutics, an ophthalmic biopharmaceutical company, today announced that it has granted Orphan Drug Designation by the Food and Drug Administration received for his anti-viral therapy, ganciclovir, for the treatment of acute herpetic keratitis. The product Laboratoires Thea Laboratoires Thea in Europe under the brand name Virgan . Sirion licensed the rights to Virgan for the United States of Laboratoires Thea in January 2007..
Sirion Therapeutics,Healthiestcret: A Leafy-up OfficeZamioculcas zamiifolia : you have to water the plant every two weeks at most, says life. Its roots retain moisture well, if you forget to go and leave. Continue reading